
    
      Prospective, randomized, triple arm study. The study population will include all consecutive
      diabetic patients within 24 months undergoing elective second generation DES implantation for
      de novo coronary artery disease. In the randomization process all participating centers will
      be equally stratified to avoid statistical unbalance.
    
  